Product Clinical Trials

Evidence Based Efficacy

As a pioneer in human studies in cannabinoids, funded by the NIH, our products are a result of evidence-based efficacy. With significant results in appetite suppression, pain, sleep, anxiety and skin conditions, we hope you enjoy our remedies.

• Double-blind clinical studies show that patients reported a drop in mild to moderate pain (Chong 2019)
• Double-blind clinical studies show a 3-point drop in anxiety (MRS score)
• Double-blind clinical studies show that 91% of the patients reported improvement in sleep and more dreaming
• Double-blind clinical studies show statistical reduction in the body’s inflammation
• Double-blind clinical studies show statistical reduction in blood sugar levels
• Double-blind clinical studies show statistical reduction in blood pressure
• Double-blind clinical studies show statistical reduction average 8-14 pounds in 90 days
• Double-blind clinical studies show statistical reduction average up to 4” abdominal girth
• Double-blind clinical studies show significant increase in the calories burned within 90 days
• Double-blind clinical studies show significant increase in deep sleep
• Double-blind clinical studies show significant increase in REM sleep
• Double-blind clinical studies show significant decrease in awake minutes per night
• Double-blind clinical studies show significant decrease in resting heart rate